|
⚲
|
| Keyboard |
| Sniecinski Megan
✚
|
|
|---|---|
| CIK # | 0001781480 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001781480] | |
| 4 | [0001781480] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sniecinski Megan | |
| Praxis Precision Medicines Inc | |
| Biocryst Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Praxis Precision Medicines Inc PRAX
Common Stock
|
2026-01-12 | Tax withheld | 885 | $275.74 | 244,030 |
|
Praxis Precision Medicines Inc PRAX
Common Stock
|
2026-01-10 | Tax withheld | 1,087 | $288.45 | 313,545 |
|
Praxis Precision Medicines Inc PRAX
Common Stock
|
2026-01-08 | Grant | 9,625 | $0.00 | |
|
Praxis Precision Medicines Inc PRAX
Stock Option (Right to Buy) · derivative
|
2026-01-08 | Grant | 7,700 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2020-12-15 | Grant | 225,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2019-12-17 | Grant | 202,000 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2019-11-18 | Buy | 45,000 | $1.45 | 65,250 |
|
Biocryst Pharmaceuticals Inc BCRX
Emp. Stock Option (Right to Buy) · derivative
|
2019-07-01 | Grant | 500,000 | $0.00 |